Don't Assume Your ANDA Will Be Designated, US FDA Tells Aspiring Competitive Generic Therapy Sponsors

Final guidance clarifies that all sponsors who want CGT designation, which can bring exclusivity upon approval, should request it.

FDA entrance sign 2016
The FDA clarified some aspects of the competitive generic therapies program in its final guidance. • Source: File photo

More from Generics

More from Biosimilars & Generics